Exclusive License Agreement by and between SELLAS LIFE SCIENCES GROUP, Inc., SLSG Limited, LLC, and 3D medicines INC. December 7, 2020Exclusive License Agreement • January 28th, 2021 • SELLAS Life Sciences Group, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 28th, 2021 Company Industry JurisdictionThis Exclusive License Agreement (this “Agreement”) is entered into as of the 7th day of December, 2020 (the “Effective Date”), by and among SELLAS Life Sciences Group, Inc., a Delaware corporation with an office address located at Times Square Tower, 7 Times Square, Suite 2503, New York, New York 10036, United States of America (“SELLAS Parent”), SLSG Limited, LLC, a Delaware limited liability company with an office address located at Times Square Tower, 7 Times Square, Suite 2503, New York, New York 10036, United States of America (“SELLAS Sub,” and together with SELLAS Parent and its other Affiliates, “SELLAS”), and 3D Medicines Inc., a corporation organized under the laws of the Cayman Islands with its legal address located at Cricket Square, Hutchins Drive, P.O. Box 2681, Grand Cayman KY1-1111, Cayman Islands (“3DMed”). SELLAS and 3DMed are each referred to herein by name or as a “Party” or, collectively, as “Parties.”